» Authors » George L Zorn 3rd

George L Zorn 3rd

Explore the profile of George L Zorn 3rd including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 1600
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerdisch M, Garrett Jr H, Mumtaz M, Grehan J, Castillo-Sang M, Miller J, et al.
Innovations (Phila) . 2022 Nov; 17(6):463-470. PMID: 36373654
Objective: Patients with elevated CHADS-VASc scores are at high risk for atrial fibrillation (AF) and thromboembolic events (TE) after cardiac surgery. Left atrial appendage exclusion (LAAE) is a permanent, continuous...
2.
Downey P, Thors A, Johnson P, Gupta K, Wallisch W, Almoghrabi O, et al.
J Vasc Surg Cases Innov Tech . 2022 May; 8(2):214-217. PMID: 35493339
Patients with type B aortic dissection (TBAD) often present as an emergency. Operative repair of TBAD can be indicated for selected patients in the setting of hemodynamic instability or rupture....
3.
Forrest J, Deeb G, Yakubov S, Rovin J, Mumtaz M, Gada H, et al.
J Am Coll Cardiol . 2022 Mar; 79(9):882-896. PMID: 35241222
Background: The Evolut Low Risk Trial (Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients) showed that transcatheter aortic valve replacement (TAVR) with a supra-annular, self-expanding valve was noninferior...
4.
Mumtaz M, Wyler von Ballmoos M, Deeb G, Popma J, Van Mieghem N, Kleiman N, et al.
Ann Thorac Surg . 2020 Nov; 112(3):778-785. PMID: 33217396
Background: An increasing body of evidence suggests that packed red blood cell (PRBC) transfusion may be associated with increased morbidity and mortality after transcatheter and surgical aortic valve replacement. It...
5.
Wyler von Ballmoos M, Reardon M, Williams M, Mangi A, Kleiman N, Yakubov S, et al.
Cardiovasc Revasc Med . 2020 Nov; 26:12-16. PMID: 33199247
Background: Paravalvular regurgitation (PVR) following transcatheter aortic valve replacement (TAVR) is associated with increased morbidity and mortality. PVR continues to plague TAVR jeopardizing long-term results. New device iterations, such as...
6.
Popma J, Deeb G, Yakubov S, Mumtaz M, Gada H, OHair D, et al.
N Engl J Med . 2019 Mar; 380(18):1706-1715. PMID: 30883053
Background: Transcatheter aortic-valve replacement (TAVR) is an alternative to surgery in patients with severe aortic stenosis who are at increased risk for death from surgery; less is known about TAVR...
7.
Gleason T, Reardon M, Popma J, Deeb G, Yakubov S, Lee J, et al.
J Am Coll Cardiol . 2018 Sep; 72(22):2687-2696. PMID: 30249462
Background: The CoreValve U.S. Pivotal High Risk Trial was the first randomized trial to show superior 1-year mortality of transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement...
8.
Forrest J, Mangi A, Popma J, Khabbaz K, Reardon M, Kleiman N, et al.
JACC Cardiovasc Interv . 2018 Jan; 11(2):160-168. PMID: 29348010
Objectives: This study sought to evaluate the Medtronic Evolut PRO Transcatheter Aortic Valve System in patients with severe symptomatic aortic stenosis. Background: A next-generation self-expanding transcatheter aortic valve was designed...
9.
Deeb G, Chetcuti S, Yakubov S, Patel H, Grossman P, Kleiman N, et al.
Ann Thorac Surg . 2018 Jan; 105(4):1129-1136. PMID: 29307456
Background: This analysis evaluates the relationship of annular size to hemodynamics and the incidence of prosthesis-patient mismatch (PPM) in surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR)...
10.
Conte J, Hermiller Jr J, Resar J, Deeb G, Gleason T, Adams D, et al.
Semin Thorac Cardiovasc Surg . 2017 Dec; 29(3):321-330. PMID: 29195573
Procedural complications following transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) are usually reported as retrospective analyses. We report the first comparison of complications following SAVR or...